Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 14 of 14 for “"Cardioplegic solution"”.
-
Retrograde delivery of cardioplegic solution in adult cardiac surgery: a clinical evaluation
Promotores : L. Lacquet, T. van der Werf en W. Flameng
-
The Cardio-protective Efficacy of Cardioplegic Solution Supplemented with Sildenafil in Neonatal Pig Model of Cardiopulmonary Bypass and Cardioplegic Arrest
… to 60 minutes ischaemia using cardioplegia solution, followed by 20 minutes reperfusion on CPB, weaned off CPB, and eventually terminated at 60 minutes of reperfusion. The cardioplegia treatment arms were control (St Thomas solution) (n=39), 10 nM Sildenafil (n=25) and 70 nM Sildenafil …
-
Optimization of techniques for cardiac preservation: Phosphorus-31 NMR spectroscopic and functional studies in isolated rat and pig hearts.
The effects of cardioplegic and reperfusion conditions on energy metabolites and cardiac function were investigated in order to define better conditions for heart preservation (4 or 8 hrs). Myocardial energy metabolites (ATP, PCr and inorganic phosphate), intracellular pH and contractile function …
-
Η οξεία βλάβη του ενδοθηλίου των φλεβικών μοσχευμάτων που προκαλείται από τη χορήγηση ορθοδρομικής καρδιοπληγίας δια αυτών σε επεμβάσεις αορτοστεφανιαίας παράκαμψης
… artery bypass grafting (CABG). However, the cardioplegic solution may disrupt the vein endothelium and contribute to late vein graft atherosclerotic disease. This study aimed at evaluating the possible impact of the cardioplegic solution on vein graft endothelium. Methods: 52 patients (16 …
-
Μελέτη του οξειδωτικού stress στο μυοκάρδιο μετά από πειραματική πρόκληση ισχαιμίας/επαναιμάτωσης και η επίδραση του αντιοξειδωτικού παράγοντα U74389G (16-demesthyl tirilazad)
… All animals underwent 45 minutes of ischemic cardioplegic arrest, with U-74389G addition to the standard cardioplegic solution, while controls underwent the same procedure without U-74389G. Creatine kinase-MB isoenzyme (CK-MB) and cardiac troponin T (cTnT) levels were measured immediately …
-
Microvascular dysfunction during cardiac preservation.
… the arrest and immersion of the heart in cold cardioplegic solution, the composition of which is designed to provide for the reduced metabolic demands of the cold, arrested muscle. These methods have extended the preservation period to approximately 6 hours; however, hearts cannot be held …
-
Μελέτη του διεγχειρητικού ενδοθηλιακού τραύματος των εμφυτευθέντων φλεβικών μοσχευμάτων κατά την αορτοστεφανιαία παράκαμψη και συσχέτιση με διεγχειρητικά μέτρα προστασίας
… Multiple factors, including graft storage solution from the time of harvesting to the time of graft implantation, influence endothelial integrity and subsequently long-term graft patency. Therefore, it is imperative to ideally store the unaffected by the harvesting procedure parts of the …
-
Das atypische Hämolytisch-Urämische Syndrom in der kardiovaskulären Chirurgie
… intraoperative course: the applied quantity of cardioplegic solution, the use of a (hypothermic) circulatory arrest and the exact time on the CPB. Among the secondary endpoints mention should be made of the correlation between postoperative aHUS and other complications (such as bleedings, need …
-
The use of a radioiodinated fatty acid analogue in the study of myocardial ischemia and infarction
… phase) were observed with Iso-osmolar (Tyers) solution. There were no significant differences for either the Iso-osmolar + superoxide dismutase (SOD) or Iso-osmolar + allopurinol. Also there was no significant difference in t½ values between the three areas of the left ventricle (apex, septal …
-
Αποδέσμευση από την εξωσωματική κυκλοφορία και ιόντα ασβεστίου
… bolus or continuous infusion of the enriched K+ cardioplegic solution provides protection on the myocardium, due to the beneficial cardiac arrest. During the rewarming and reperfusionperiod, following cross clamp, the myocardial oxygen consumption should be decreasead, due to the decresed reserve …
-
Development of a non-depolarising normakalaemic cardioprotective preservation solution for use in orthotopic heart transplantation
Background: Since the 1970s preservation solutions for donor hearts for transplantation have relied on hypothermic depolarising potassium to arrest and protect the heart. Despite many studies investigating improvements in composition, no preservation solution has been able to provide adequate …
-
A novel cardioprotective therapy : adenosine and lidocaine solution in an in vivo rat model of acute myocardial ischemia-reperfusion
… an adenosine and lidocaine (AL) non-depolarizing cardioplegic arrest solution conferred superior protection during arrest and recovery compared with the hyperkalemic depolarizing St. Thomas’ Hospital cardioplegic solution in isolated rat hearts. The aim of this thesis was to extend those findings …
-
ΠΡΟΣΤΑΣΙΑ ΤΟΥ ΜΥΟΚΑΡΔΙΟΥ ΣΕ ΕΓΧΕΙΡΗΣΕΙΣ ΑΝΟΙΚΤΗΣ ΚΑΡΔΙΑΣ ΜΕ ΚΑΡΔΙΟΠΛΗ- ΓΙΑ ΕΜΠΛΟΥΤΙΣΜΕΝΗ ΜΕ ΑΔΕΝΟΣΙΝΗ
Η ΚΑΡΔΙΟΠΡΟΣΤΑΤΕΥΤΙΚΗ ΔΡΑΣΗ ΤΗΣ ΑΔΕΝΟΣΙΝΗΣ, ΣΑΝ ΠΡΟΣΘΗΚΗ ΣΤΗΝ ΑΙΜΑΤΙΚΗ ΚΑΡΔΙΟΠΛΗΓΙΑ, ΑΞΙΟΛΟΓΗΘΗΚΕ ΣΕ 20 ΑΣΘΕΝΕΙΣ (10 ΜΑΡΤΥΡΕΣ ΚΑΙ 10 ΤΗΣ ΟΜΑΔΑΣ ΕΛΕΓΧΟΥ) ΠΟΥ ΥΠΟΒΛΗΘΗΚΑΝ ΣΕΕΚΛΕΚΤΙΚΗ ΧΕΙΡΟΥΡΓΙΚΗ ΕΠΑΝΑΙΜΑΤΩΣΗ ΤΟΥ ΜΥΟΚΑΡΔΙΟΥ. ΟΙ ΣΥΓΚΕΝΤΡΩΣΕΙΣ ΤΗΣ ΑΔΕΝΟΣΙΝΗΣ ΠΟΥ ΜΕΛΕΤΗΘΗΚΑΝ ΗΤΑΝ 160ΜΜΟL /L ΓΙΑ ΤΑ ΠΡΩΤΑ …